Law Firm Investigates Option Care Health Amid M&A Concerns
Monteverde & Associates PC has launched a shareholder investigation into Option Care Health (NASDAQ: OPCH), the M&A-focused class action firm announced.
A New York-based class action law firm has opened an investigation into Option Care Health, Inc., a publicly traded home infusion therapy company listed on the Nasdaq under the ticker OPCH, according to an announcement dated October 11, 2026.
Monteverde & Associates PC, led by attorney Juan Monteverde, is conducting the probe on behalf of shareholders. The firm has previously recovered millions of dollars for investors and was recognized as a Top 50 firm in the 2025 ISS Securities Class Action Services Report, lending it a degree of institutional credibility in the shareholder litigation space.
Read more Law Firm Investigates Pacira BioSciences Over Shareholder Rights →
Investigations of this nature are typically launched when a law firm believes shareholders may have been harmed by inadequate disclosures, unfair deal terms, or potential breaches of fiduciary duty — particularly in the context of mergers and acquisitions. No formal lawsuit has been announced at this stage, and the investigation represents a preliminary step in the legal process.
Shareholders of Option Care Health who have concerns about their holdings or wish to learn more about their legal rights are generally encouraged to contact the investigating firm directly before any legal deadlines, such as lead plaintiff cutoff dates, may apply. The outcome of such investigations varies widely, ranging from no further action to full class action litigation.
Continue reading at All Financial Services & Investing.
